# Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

> **NCT06099873** · PHASE3 · COMPLETED · sponsor: **Nanjing Zenshine Pharmaceuticals** · enrollment: 361 (actual)

## Conditions studied

- Respiratory Viral Infection

## Interventions

- **DRUG:** ZX-7101A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06099873
- **Lead sponsor:** Nanjing Zenshine Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-30
- **Primary completion:** 2025-02-13
- **Final completion:** 2025-02-13
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099873, "Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT06099873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*